Get the Stockscreener App
30.06
4.78%
-1.51
After Hours:
29.50
-0.56
-1.86%
Twist Bioscience Corp stock is traded at $30.06, with a volume of 1.91M.
It is down -4.78% in the last 24 hours and down -3.25% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$31.57
Open:
$31
24h Volume:
1.91M
Relative Volume:
1.06
Market Cap:
$1.81B
Revenue:
$362.27M
Net Income/Loss:
$-85.19M
P/E Ratio:
-20.73
EPS:
-1.45
Net Cash Flow:
$-68.71M
1W Performance:
-10.46%
1M Performance:
-3.25%
6M Performance:
-23.39%
1Y Performance:
-28.51%
1-Day Range:
$29.71
$31.40
1-Week Range:
$29.71
$34.08
52-Week Range:
$24.07
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
30.06 | 1.91B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 31,379 Shares - MarketBeat
Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 1,016 Shares - MarketBeat
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Stephens & Co. Initiates Coverage on TWST with Overweight Rating - GuruFocus
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference - Business Wire
Stephens initiates Twist Bioscience stock with Overweight rating, $41 target - Investing.com
Twist Bioscience Corporation (NASDAQ:TWST) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Live market analysis of Twist Bioscience CorporationPortfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Will Twist Bioscience Corporation outperform the marketEarnings Overview Report & Technical Entry and Exit Tips - newser.com
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Is Twist Bioscience Corporation (0ME) stock prepared for digital transitionJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
What does recent volatility data suggest for Twist Bioscience CorporationWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - newser.com
Combining machine learning predictions for Twist Bioscience CorporationWeekly Trend Summary & Safe Capital Investment Plans - newser.com
Long term hold vs stop loss in Twist Bioscience CorporationMarket Risk Analysis & Consistent Return Strategy Ideas - newser.com
Is Twist Bioscience Corporation stock ready for breakoutJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
What insider trading reveals about Twist Bioscience Corporation stockInsider Selling & Weekly High Return Stock Opportunities - newser.com
Will Twist Bioscience Corporation bounce back from current support - newser.com
Is Twist Bioscience Corporation (0ME) stock trading at attractive multiples2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
Jennison Associates LLC Has $22.75 Million Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
How sustainable is Twist Bioscience Corporation stock dividend payoutJuly 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
Is Twist Bioscience Corporation forming a reversal patternWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - newser.com
[Form 4] Twist Bioscience Corp Insider Trading Activity - Stock Titan
TWST insider Form 4: 29,518 PSUs credited; holdings 128,228 - Stock Titan
TWST Form 4: 35,513 PSUs credited; 60% vest by Oct 1, 2026 - Stock Titan
TWST Form 4: CAO reports 5,633-share PSU award, vesting in 2026 - Stock Titan
Form 4: TWST CFO reports 25,000 shares; 60% vests by Oct 1, 2026 - Stock Titan
Will Twist Bioscience Corporation stock continue upward momentumJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
How Twist Bioscience Corporation stock compares to market leadersWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Will Twist Bioscience Corporation stock return to pre crisis levels - newser.com
Is Twist Bioscience Corporation stock undervalued vs historical averagesEntry Point & Safe Entry Momentum Tips - newser.com
Why Twist Bioscience Corporation (0ME) stock appeals to dividend investorsRate Hike & Daily Market Momentum Tracking - fcp.pa.gov.br
Top chart patterns to watch in Twist Bioscience Corporation2025 Stock Rankings & Consistent Profit Alerts - newser.com
Volatility clustering patterns for Twist Bioscience CorporationPortfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for Twist Bioscience Corporation holdersDividend Hike & Safe Capital Growth Plans - newser.com
Is Twist Bioscience Corporation stock in correction or buying zoneJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Twist Bioscience Stock Soars 7.16%, Hits Intraday High of $34.18 - Markets Mojo
Will Twist Bioscience Corporation stock beat EPS estimatesMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
Twist Bioscience COO Finn sells $69k in shares By Investing.com - Investing.com Canada
Twist Bioscience COO Finn sells $69k in shares - Investing.com
Twist Bioscience Exec Sells Shares to Cover Tax Obligations - TradingView
TWST Form 4: COO sold 2,240 shares at $30.875 for tax withholding - Stock Titan
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
6.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):